Immunology of protection from Ebola virus infection.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25947159.
- Also identified by DOI 10.1126/scitranslmed.aaa8202.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A December 2014 meeting reviewed Ebola virus immunology relevant to vaccine development, including Ebola prevention, immunity, assay standardization, and regulatory considerations. Vaccinated humans appear to achieve immune responses comparable in magnitude with those associated with protection in nonhuman primates, suggesting that immunological data could be used to demonstrate vaccine efficacy.
Medical subject headings
- Ebola Vaccines
- Hemorrhagic Fever, Ebola